Metacrine, Inc.
CIK 0001634379
Revenue (TTM)
—
Q3 Nov 2022
Net Income (TTM)
−$42.99M
−475.1% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$1.56
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
−$47.17M
Q3 Nov 2022
Cash
$52.75M
Q3 Nov 2022
Total Debt
$13.79M
Q3 Nov 2022
Shares Outstanding
42.57M sh
Q3 Nov 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.